WHWK
Income statement / Annual
Last year (2024), Whitehawk Therapeutics Inc's total revenue was $25.98 M,
an increase of 6.69% from the previous year.
In 2024, Whitehawk Therapeutics Inc's net income was -$63.69 M.
See Whitehawk Therapeutics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$25.98 M |
$24.35 M |
$15.22 M |
$1.12 M |
$14.58 M |
$749.00 K |
| Cost of Revenue |
$54.05 M
|
$51.74 M
|
$34.00 M
|
$19.67 M
|
$15.01 M
|
$11.06 M
|
| Gross Profit |
-$28.07 M
|
-$27.38 M
|
-$18.78 M
|
-$18.55 M
|
-$428.00 K
|
-$10.32 M
|
| Gross Profit Ratio |
-1.08
|
-1.12
|
-1.23
|
-16.56
|
-0.03
|
-13.77
|
| Research and Development Expenses |
$51.03 M
|
$48.93 M
|
$32.66 M
|
$19.67 M
|
$15.01 M
|
$11.06 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$18.51 M
|
$2.12 M
|
$1.85 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$36.75 M
|
$44.55 M
|
$40.18 M
|
$18.51 M
|
$2.12 M
|
$1.85 M
|
| Other Expenses |
-$48.39 M
|
-$48.93 M
|
-$28.94 M
|
$54.49 M
|
-$15.01 M
|
-$11.06 M
|
| Operating Expenses |
$39.39 M
|
$44.55 M
|
$43.90 M
|
$92.67 M
|
$2.12 M
|
$1.85 M
|
| Cost And Expenses |
$93.44 M
|
$96.29 M
|
$77.90 M
|
$112.34 M
|
$17.13 M
|
$12.92 M
|
| Interest Income |
$3.93 M
|
$6.40 M
|
$2.40 M
|
$13.00 K
|
$41.00 K
|
$0.00
|
| Interest Expense |
$154.00 K
|
$231.00 K
|
$230.00 K
|
$665.00 K
|
$815.00 K
|
$83.94 K
|
| Depreciation & Amortization |
$193.00 K
|
$169.00 K
|
$159.00 K
|
$105.00 K
|
$9.00 K
|
$5.98 K
|
| EBITDA |
-$64.63 M |
-$71.76 M |
-$58.80 M |
-$36.96 M |
-$2.54 M |
-$12.16 M |
| EBITDA Ratio |
-2.49
|
-2.95
|
-3.86
|
-33
|
-0.17
|
-16.24
|
| Operating Income Ratio |
-2.6
|
-2.95
|
-4.12
|
-99.3
|
-0.17
|
-16.25
|
| Total Other Income/Expenses Net |
$3.77 M
|
$6.17 M
|
$2.17 M
|
$1.13 M
|
-$927.00 K
|
-$83.94 K
|
| Income Before Tax |
-$63.69 M
|
-$65.77 M
|
-$60.51 M
|
-$110.09 M
|
-$3.48 M
|
-$12.25 M
|
| Income Before Tax Ratio |
-2.45
|
-2.7
|
-3.98
|
-98.29
|
-0.24
|
-16.36
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$2.00 K
|
$2.00 K
|
$1.30 K
|
| Net Income |
-$63.69 M
|
-$65.77 M
|
-$60.51 M
|
-$110.09 M
|
-$3.48 M
|
-$12.26 M
|
| Net Income Ratio |
-2.45
|
-2.7
|
-3.98
|
-98.29
|
-0.24
|
-16.36
|
| EPS |
-2.36 |
-2.44 |
-2.69 |
-12.41 |
-0.21 |
-1.65 |
| EPS Diluted |
-2.36 |
-2.44 |
-2.69 |
-12.41 |
-0.21 |
-1.65 |
| Weighted Average Shares Out |
$27.03 M
|
$26.92 M
|
$22.51 M
|
$8.87 M
|
$20.84 M
|
$7.42 M
|
| Weighted Average Shares Out Diluted |
$27.03 M
|
$26.92 M
|
$22.51 M
|
$8.92 M
|
$17.63 M
|
$8.02 M
|
| Link |
|
|
|
|
|
|
